Renal Cell Carcinoma
Molecular Targets and Clinical Applications
???The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.?
CHF 211.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V301:
Libri-Titel folgt in ca. 2 Arbeitstagen
Produktdetails
Weitere Autoren: Figlin, Robert A. (Hrsg.) / Motzer, Robert (Hrsg.)
- ISBN: 978-1-4939-1621-4
- EAN: 9781493916214
- Produktnummer: 16583722
- Verlag: Springer-Verlag GmbH
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 613 S.
- Masse: H24.1 cm x B16.0 cm x D3.9 cm 1'103 g
- Auflage: 3rd edition
- Abbildungen: Book
- Gewicht: 1103
Über den Autor
Ronald M Bukowski MDEmeritus Staff PhysicianCleveland Clinic Taussig Cancer CenterProfessor Emeritus of MedicineCCF Lerner College of Medicine of CWRURobert Figlin MDProfessor of Medicine and Biomedical SciencesDirector, Division of Hematology OncologyDepartment of Medicine, Cedars-Sinai Medical CenterAssociate Director for Academic ProgramsSamuel Oschin Comprehensive Cancer InstituteProfessor Emeritus of Medicine and UrologyDavid Geffen School of Medicine at UCLARobert Motzer MDAttending PhysicianDepartment of MedicineMemorial Sloan-Kettering Cancer CenterProfessor of MedicineWeil Medical College of Cornell University
1 weiteres Werk von Ronald (Hrsg.) Bukowski:
Bewertungen
Anmelden